Tools
Tools
Desprez, B, Birk, B, Blaauboer, B, Boobis, A, Carmichael, P, Cronin, MTD, Curie, R, Daston, G, Hubesch, B, Jennings, P, Klaric, M, Kroese, D, Mahony, C, Ouédraogo, G, Piersma, A, Richarz, A-N, Schwarz, M, van Benthem, J, van de Water, B and Vinken, M (2019) A mode-of-action ontology model for safety evaluation of chemicals: outcome of a series of workshops on repeated dose toxicity. Toxicology In Vitro. pp. 44-50. ISSN 0887-2333
|
Text
Paper Ontology for symplectic 3 April 19.pdf - Accepted Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (287kB) | Preview |
Abstract
Repeated dose toxicity evaluation aims at assessing the occurrence of adverse effects following chronic or repeated exposure to chemicals. Non-animal approaches have gained importance in the last decades because of ethical considerations as well as due to scientific reasons calling for more human-based strategies. A critical aspect of this challenge is linked to the capacity to cover a comprehensive set of interdependent mechanisms of action, link them to adverse effects and interpret their probability to be triggered in the light of the exposure at the (sub)cellular level. Inherent to its structured nature, an ontology addressing repeated dose toxicity could be a scientific and transparent way to achieve this goal. Additionally, repeated dose toxicity evaluation through the use of a harmonized ontology should be performed in a reproducible and consistent manner, while mimicking as accurately as possible human physiology and adaptivity. In this paper, the outcome of a series of workshops organized by Cosmetics Europe on this topic is reported. As such, this manuscript shows how experts set critical elements and ways of establishing a mode-of-action ontology model as a support to risk assessors aiming to perform animal-free safety evaluation of chemicals based on repeated dose toxicity data.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | 1115 Pharmacology and Pharmaceutical Sciences |
| Subjects: | R Medicine > RM Therapeutics. Pharmacology |
| Divisions: | Pharmacy & Biomolecular Sciences |
| Publisher: | Elsevier |
| Date Deposited: | 03 Apr 2019 09:46 |
| Last Modified: | 04 Sep 2021 09:32 |
| DOI or ID number: | 10.1016/j.tiv.2019.04.005 |
| URI: | https://researchonline.ljmu.ac.uk/id/eprint/10484 |
 |
View Item |